Sex differences in the efficacy and safety of SARS-CoV-2 vaccination in residents of long-term care facilities: insights from the GeroCovid Vax study
暂无分享,去创建一个
S. Volpato | M. Noale | R. Antonelli Incalzi | V. Raparelli | G. Fedele | A. Abbatecola | P. Stefanelli | P. Leone | A. Malara | C. Trevisan | A. Di Lonardo | A. Palmieri | I. Schiavoni | G. Onder
[1] G. Onder,et al. Diabetes Affects Antibody Response to SARS-CoV-2 Vaccination in Older Residents of Long-Term Care Facilities: Data From the GeroCovid Vax Study. , 2022, Diabetes care.
[2] S. Hung,et al. Association of malnutrition with SARS-CoV-2 vaccine response in patients undergoing hemodialysis , 2022, Clinical Nutrition.
[3] S. Cramer,et al. Association of Frailty, Age, and Biological Sex With Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine–Induced Immunity in Older Adults , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] M. Zhao,et al. Clinical Variables Correlate with Serum Neutralizing Antibody Titers after COVID-19 mRNA Vaccination in an Adult, US-based Population , 2022, medRxiv.
[5] E. Isomura,et al. Impact of age, sex and medical history on adverse reactions to the first and second dose of BNT162b2 mRNA COVID-19 vaccine in Japan: a cross-sectional study , 2022, BMC Infectious Diseases.
[6] P. Diggle,et al. Population antibody responses following COVID-19 vaccination in 212,102 individuals , 2022, Nature communications.
[7] D. Montano. Frequency and Associations of Adverse Reactions of COVID-19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States , 2022, Frontiers in Public Health.
[8] G. Onder,et al. Monitoring COVID-19 vaccine use in Italian long term care centers: The GeroCovid VAX study , 2022, Vaccine.
[9] J. Olgin,et al. Analysis of COVID-19 Vaccine Type and Adverse Effects Following Vaccination , 2021, JAMA network open.
[10] H. Naruse,et al. Immunogenicity of BNT162b2 mRNA COVID-19 Vaccine in Patients with Cardiovascular Disease , 2021, Journal of clinical medicine.
[11] B. Sarubbi,et al. COVID-19 vaccination in adults with congenital heart disease: Real-world data from an Italian tertiary centre , 2021, International Journal of Cardiology Congenital Heart Disease.
[12] A. Davenport,et al. Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients , 2021, The Lancet.
[13] A. Bachstetter,et al. Dysregulation of Systemic Immunity in Aging and Dementia , 2021, Frontiers in Cellular Neuroscience.
[14] David A. Drew,et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study , 2021, The Lancet Infectious Diseases.
[15] G. Shefer,et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia , 2021, Blood.
[16] S. Volpato,et al. Are vaccines against COVID-19 tailored to the most vulnerable people? , 2021, Vaccine.
[17] L. Piemonti,et al. Robust neutralizing antibodies to SARS-CoV-2 develop and persist in subjects with diabetes and COVID-19 pneumonia. , 2021, The Journal of clinical endocrinology and metabolism.
[18] Xiao-ning Xu,et al. Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly , 2020, Frontiers in Immunology.
[19] C. Franceschi,et al. Inflammaging, hormesis and the rationale for anti-aging strategies , 2020, Ageing Research Reviews.
[20] L. L. Cunha,et al. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response , 2020, Frontiers in Immunology.
[21] Harnish Mukesh Naik,et al. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population , 2020, medRxiv.
[22] C. Nemeroff,et al. The Bidirectional Relationship of Depression and Inflammation: Double Trouble , 2020, Neuron.
[23] E. Dong,et al. An interactive web-based dashboard to track COVID-19 in real time , 2020, The Lancet Infectious Diseases.
[24] P. Rochon,et al. Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century , 2019, EClinicalMedicine.
[25] J. Banchereau,et al. Sexual-dimorphism in human immune system aging , 2019, Nature Communications.
[26] L. Faccioli,et al. Effects of natural aging and gender on pro-inflammatory markers , 2019, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[27] N. Curtis,et al. Factors That Influence the Immune Response to Vaccination , 2019, Clinical Microbiology Reviews.
[28] Christine Nardini,et al. Vaccination in the elderly: The challenge of immune changes with aging. , 2018, Seminars in immunology.
[29] G. Neigh,et al. Sex differences in the neuro-immune consequences of stress: Focus on depression and anxiety , 2018, Brain, Behavior, and Immunity.
[30] F. Hoffmann,et al. Variations over time in the effects of age and sex on hospitalization rates before and after admission to a nursing home: A German cohort study. , 2017, Maturitas.
[31] S. Klein,et al. Sex differences in immune responses , 2016, Nature Reviews Immunology.
[32] S. Anticoli,et al. The influence of sex and gender on immunity, infection and vaccination. , 2016, Annali dell'Istituto superiore di sanita.
[33] J. Berkley,et al. Immune Dysfunction as a Cause and Consequence of Malnutrition , 2016, Trends in immunology.
[34] S. Klein,et al. Sex and Gender Impact Immune Responses to Vaccines Among the Elderly. , 2015, Physiology.
[35] C. Franceschi,et al. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.
[36] M. Irwin,et al. Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] S. Razavi,et al. Antibody response to influenza immunization in coronary artery disease patients: a controlled trial. , 2009, Vaccine.
[38] D. Bovbjerg,et al. Psychological stress and antibody response to influenza vaccination: A meta-analysis , 2009, Brain, Behavior, and Immunity.
[39] E. Carraro,et al. Risk factors for poor immune response to influenza vaccination in elderly people. , 2006, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[40] John J. Treanor,et al. Psychological Stress and Antibody Response to Influenza Vaccination: When Is the Critical Period for Stress, and How Does It Get Inside the Body? , 2004, Psychosomatic medicine.
[41] D. Stott,et al. Serological response to influenza vaccination and nutritional and functional status of patients in geriatric medical long-term care. , 1999, Age and ageing.
[42] E. Remarque,et al. Functional disability and antibody response to influenza vaccine in elderly patients in a Dutch nursing home , 1996, BMJ.
[43] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .